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Abstract
An asymptomatic 67-year-old man presented with a left supraclavicular lymph node that enlarged
over a 2-month period which was biopsied. Pathologic features were consistent with involvement by
metastatic seminoma and follicular lymphoma, follicular pattern, grade 1 (of 3). Staging Positron
Emission Tomography/Computed Tomography scans indicated several areas of enlarged lymph
nodes. The patient completed chemotherapy with bleomycin, etoposide, and cisplatin chemotherapy.
This is the first reported case of metastatic seminoma and follicular lymphoma occurring in the same
lymph node. No obvious pathophysiologic link exists between these two malignancies and there are
no shared common risk factors. Given the natural history of these two malignancies, if this patient
develops recurrent lymphadenopathy, it will be difficult to identify whether the enlarged lymph nodes
represent recurrent seminoma or follicular lymphoma without a biopsy of each pathologically
enlarged node. Similarly, Fluorodeoxyglucose- Positron Emission Tomography is known to be active
in both seminoma and follicular lymphoma, making this scan non-specific in this patient. Finally, this
patient had no baseline elevation in any germ cell tumor marker. Thus, serum tumor markers cannot
be relied upon as surrogates for response to chemotherapy or as identifiers of relapsed seminoma.
Case presentation
An asymptomatic 67-year-old white, American man
presented with a left supraclavicular lymph node that
enlarged over a 2-month period. His primary care
physician recommended a biopsy.
The left supraclavicular lymph node was partially effaced
by neoplastic nodules of small lymphocytes with
cleaved nuclei and scant cytoplasm intermixed with rare
centroblasts, and by metastatic seminoma which is
associated with a non-necrotizing granulomatous reaction
(Figure 1a, b). The neoplastic lymphocytes were positive
for CD20 (Figure 1c) and CD10 (Figure 1d) and showed
monotypic surface immunoglobulin lambda light chain
expression by flow cytometric analysis. The anti-apoptotic
marker bcl-2 (Figure 1e) was reactive in a subset of the
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(page number not for citation purposes)follicles. The seminoma cells were positive for c-kit
(Figure 1f) and negative for keratin and for melanocytic
and lymphocytic markers (not shown). The overall
features were consistent with involvement by metastatic
seminoma and follicular lymphoma, follicular pattern,
grade 1 (of 3).
Thepatienthadnofevers,chills,nightsweats,unintentional
weight loss, or other systemic symptoms. He had not noted
any testicular masses or pain. He was not experiencing
shortness of breath or cough. His past medical history was
notable only for benign prostatic hypertrophy, with a
prostate biopsy showing no evidence of malignancy, and
Dupuytren’s contracture of the right hand.
Physical examination was notable for a healed left
supraclavicular lymphadenectomy scar, no other palpable
lymph nodes and a slightly atrophic left testicle with no
palpable testicular masses. A serum prostate-specific
antigen (PSA) was 3.23 ng/ml, serum beta-human
chorionic gonadotrophin (HCG) was undetectable, and
a serum alpha-fetoprotein (AFP) was 4.2 ng/ml (normal
range 0-7.6 ng/ml). Serum LDH was 389 u/l (normal
range 313-618 u/l). A complete blood count with
differential, serum electrolytes, renal function, and liver
function were all within normal limits.
A scrotal ultrasound demonstrated a mildly heterogeneous
and small (2.6 × 1.3 × 2.2 cm) left testicle consistent with
atrophy as well as a small left varicocele. The right testicle
was normal (3.6 × 2.5 × 1.8 cm). Positron emission
tomography (PET) and computed tomography (CT) scan
performed approximately one month after the original
CT scan demonstrated FDG uptake in left supraclavicular
(1.5 × 0.8 cm), bilateral axillary (1.6 × 1.0 cm on left,
1.5 × 1.1 cm on right), anterior mediastinal (without
CT correlate), retroperitoneal (1.5 × 1.9 cm), and mesen-
teric (1.6 × 1.0 cm) lymph nodes. The prostate gland was
slightly enlarged and exhibited mild FDG uptake.
This is the first reported case of metastatic seminoma and
follicular lymphoma occurring in the same lymph node.
We are aware of a report of metachronous seminoma and
Hodgkin’s disease [1]. No obvious pathophysiologic link
exists between these two malignancies and there are no
shared common risk factors. The patient completed
chemotherapy with bleomycin, etoposide, and cisplatin
(BEP) and remains in complete remission over three years
later [2]. He had no specific testicular primary noted, but
did have an atrophic left testicle which could have
represented a “burnt out” primary. Although his lym-
phoma did not require therapy, these agents are also active
in lymphoid malignancies [3]. This may make evaluation
of response and monitoring for relapse difficult, as both
seminoma and follicular lymphoma would be expected to
respond to BEP. However, follicular lymphoma will
inevitably relapse after chemotherapy whereas seminoma
has a high cure rate in this setting. If this patient develops
recurrent lymphadenopathy, it will be difficult to know
whether the enlarged lymph nodes represent recurrent
seminoma or follicular lymphoma without a biopsy of
each pathologically enlarged node. Similarly, FDG-PET is
known to be active in both seminoma and follicular
lymphoma, making this scan non-specific in this patient
[4,5]. Finally, this patient had no baseline elevation in any
germ cell tumor marker. Thus, serum tumor markers
cannot be relied upon as surrogates for response to
chemotherapy or as identifiers of relapsed seminoma.
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Written informed consent was obtained from the patient
for publication of this case report and accompanying
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Figure 1. Lymph node, metastatic seminoma and follicular
lymphoma. (a) Hematoxylin and eosin, low-power
magnification. (b) Hematoxylin and eosin, high-power
magnification. (c) Immunoperoxidase stain for CD20. (d)
Immunoperoxidase stain for CD10. (e) Immunoperoxidase
stain for bcl-20. (f) Immunoperoxidase stain for c-kit.
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review from the journal’s Editor-in-Chief.
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